Clinical Trials Logo

Clinical Trial Summary

The purpose of this research study is to compare the safety and effectiveness of local injections of botulinum toxin A (Xeomin®) to an inactive test substance (placebo) in a medical condition called Restless Leg Syndrome. This study has a double blind cross over design. Cross over means that you will have two sets of injections. The first set of injections can be either Xeomin or placebo. The order of injection will be reversed at the three month point following the first injection. Double blind means neither the investigators nor you know which one of the two (Xeomin or placebo) you received.


Clinical Trial Description

Please contact the PI for details about the clinical study. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01931878
Study type Interventional
Source Yale University
Contact
Status Active, not recruiting
Phase Phase 2
Start date September 2012
Completion date July 2016

See also
  Status Clinical Trial Phase
Completed NCT01672502 - Fire Fighter Fatigue Management Program: Operation Fight Fatigue N/A
Completed NCT02085720 - Prevalence of OSAS in Chinese Elderly and Its CPAP Compliance N/A
Completed NCT03337529 - Restless Legs Syndrome in Hemodialysis Patients N/A
Completed NCT01245777 - Restless Legs Syndrome With Iron Deficiency or Anaemia in the 3rd Trimester of Pregnancy Phase 4
Completed NCT01617044 - Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome Phase 2
Recruiting NCT02016638 - Sleep Quality in Pregnancy and Its Impact on Pregnancy Outcomes N/A
Completed NCT01988129 - Fire Fighter Fatigue Management Program: Operation Healthy Sleep N/A
Completed NCT00949858 - New Data Analysis Methods for Actigraphy in Sleep Medicine N/A
Completed NCT03818243 - Circadian Character of Food Compulsions and Impulses Control Disorders in Parkinsonian Patients With and Without Resting Leg Syndrome N/A
Completed NCT00872248 - Neuraxial Anesthesia and Restless Leg Syndromes in Cesarean N/A
Completed NCT00673088 - A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Und Fasted Conditions N/A
Completed NCT00674310 - A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed Conditions N/A
Completed NCT01538147 - Restless Leg Syndrome and Severe Preeclampsia N/A
Terminated NCT02117076 - Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizantâ„¢) in Restless Leg Syndrome Phase 4
Completed NCT02386423 - RESTIFFICâ„¢ Foot Wrap Reduces Moderate to Severe Restless Leg Syndrome N/A
Recruiting NCT06233773 - The Effect of Kinesio Taping and Manual Lymph Drainage on Pregnant Women With Restless Legs Syndrome N/A